According to findings published in Cell Reports Medicine, this common carotenoid may also help the immune system fight cancer by enhancing the activity of key immune cells. The discovery points to ...
CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.
A common eye-health nutrient, zeaxanthin, may also help the body fight cancer more effectively. Scientists discovered it strengthens T cells and enhances the impact of immunotherapy treatments. Found ...
Researchers at the University of Chicago have uncovered a surprising new role for zeaxanthin, a plant-based compound best known for supporting eye ...
To model tumor biology, Emulate’s platform introduces stromal contents by tuning the extracellular matrix stiffness and composition, as well as recreating essential gradients. The method captures ...
Solid tumors are heterogeneous with an immunosuppressive tumor microenvironment, but that is not slowing the search to treat the most difficult, recalcitrant cases ...
Using a variety of laboratory and animal models, the team found that cysteine fuels the production of the antioxidant ...
13d
Why a potential anti-cancer agent stalled in trials: New enzyme insights may boost yield and purity
Researchers at the University of Bayreuth have, for the first time, deciphered key steps in the biosynthetic mechanism of the ...
Gastrointestinal (GI) cancers remain a major global health burden, accounting for substantial cancer-related morbidity and mortality worldwide. Cell-free ...
Morning Overview on MSN
Study sheds new light on telomerase, an enzyme tied to aging and cancer
Researchers have found a way to trap telomerase, the enzyme cancer cells rely on for endless division, in a stalled and non-productive state. The discovery, published in Nature Communications, used ...
An international team led by researchers at Baylor College of Medicine, Texas Children’s Hospital, McGill University and University of Pittsburgh School of Medicine has discovered what drives the ...
OverT builds scalable, cost-effective immune therapies for solid tumors using its data-driven discovery platforms NEW YORK--(BUSINESS WIRE)--#Biotech--OverT Bio, a biotechnology company developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results